SHANGHAI,March 18,2025-- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV),a leading fintech platform in China,Indonesia and the Philippines,today announced that the
HONG KONG,March 18,2025-- In 2024,Roborock,the global leader in ultra-intelligent home robotics engineered to simplify daily life,ranked once again first in global sales volume and turnover amongst R
FUZHOU,China,March 3,2025-- The 5th China Cross-Border E-commerce Trade Fair,acclaimed asthe No. 1 cross-border e-commerce exhibition in China,will take place from March 18th to 20th in Fuzhou,a south
Two-thirds of survey respondents say increased costs and reduced profitability is a challenge,with over half seeing reduced customer spending and financial challenges.
SYDNEY,Feb. 14,2025-- Infomedia Ltd (ASX: IFM) is pleased to announce that it has entered into a binding agreement to acquire 50% of European AI startup,Intellegam GmbH (Intellegam),for a purchase pri
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
- The company reports KRW373.0 billion in net sales,KRW166.3 billion in operating profit,and KRW142.4 billion in net income,reflecting year-over-year increases of 16.7%,41.2%,and 45.8%,respectively